Suppr超能文献

尿毒症的促炎作用超过了用氧化型 LDL 免疫 apoE-/- 小鼠的抗动脉粥样硬化作用。

The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.

机构信息

Department of Clinical Biochemistry, KB3011, Rigshospitalet, Blegdamsvej 9, Copenhagen, Denmark.

出版信息

Nephrol Dial Transplant. 2010 Aug;25(8):2486-91. doi: 10.1093/ndt/gfq059. Epub 2010 Feb 17.

Abstract

BACKGROUND

Uraemia increases oxidative stress, plasma titres of antibodies recognizing oxidized low-density lipoprotein (oxLDL) and development of atherosclerosis. Immunization with oxLDL prevents classical, non-uraemic atherosclerosis. We have investigated whether immunization with oxLDL might also prevent uraemia-induced atherosclerosis in apolipoprotein E knockout (apoE-/-) mice.

METHODS

ApoE-/- mice were immunized with either native LDL (n = 25), Cu(2+)-oxidized LDL (n = 25), PBS (n = 25), the apolipoprotein B-derived peptide P45 (apoB-peptide P45) conjugated to bovine serum albumin (BSA) (n = 25) or BSA (n = 25) prior to induction of uraemia by 5/6 nephrectomy (NX).

RESULTS

Immunization with oxLDL increased plasma titres of immunoglobulin G (IgG) recognizing Cu(2+)-oxLDL and malondialdehyde-modified LDL (MDA-LDL). However, 5/6 NX induced a marked increase in plasma concentrations of anti-oxLDL antibodies as well as pro-atherogenic cytokines [interleukin (IL)-2 (IL-2), IL-4, IL-6 and IL-12)] in native mouse LDL (nLDL)-, oxLDL- and PBS-immunized mice. Even though nLDL- and oxLDL-immunized mice displayed higher anti-MDA-LDL IgG titres than the PBS group, aortic atherosclerosis lesion size was not affected by immunization. Immunization with the apoB-peptide P45, which consistently reduces classical atherosclerosis in non-uraemic mice, also did not reduce lesion size in uraemic apoE-/- mice.

CONCLUSION

The results suggest that the pro-inflammatory and pro-atherogenic effect of uraemia overrules the anti-atherogenic potential of oxLDL immunization in apoE-/- mice.

摘要

背景

尿毒症会增加氧化应激、血浆中识别氧化型低密度脂蛋白(oxLDL)的抗体滴度,并促进动脉粥样硬化的发展。oxLDL 免疫接种可预防经典的非尿毒症性动脉粥样硬化。我们研究了 oxLDL 免疫接种是否也能预防载脂蛋白 E 基因敲除(apoE-/-)小鼠的尿毒症诱导的动脉粥样硬化。

方法

apoE-/-小鼠在进行尿毒症诱导(5/6 肾切除)之前,分别用天然 LDL(n = 25)、Cu(2+)-氧化 LDL(n = 25)、PBS(n = 25)、载脂蛋白 B 衍生肽 P45(apoB-peptide P45)与牛血清白蛋白(BSA)偶联物(n = 25)或 BSA(n = 25)进行免疫接种。

结果

oxLDL 免疫接种增加了识别 Cu(2+)-oxLDL 和丙二醛修饰 LDL(MDA-LDL)的 IgG 抗体的血浆滴度。然而,5/6 NX 在天然 LDL(nLDL)、oxLDL 和 PBS 免疫接种的小鼠中引起了抗 oxLDL 抗体以及促动脉粥样硬化细胞因子[白细胞介素(IL)-2(IL-2)、IL-4、IL-6 和 IL-12]的血浆浓度的显著增加。尽管 nLDL 和 oxLDL 免疫接种的小鼠显示出比 PBS 组更高的抗 MDA-LDL IgG 滴度,但免疫接种并没有影响主动脉粥样硬化病变的大小。apoB-peptide P45 的免疫接种可一致降低非尿毒症小鼠的经典动脉粥样硬化,在尿毒症 apoE-/- 小鼠中也不能减少病变大小。

结论

这些结果表明尿毒症的促炎和促动脉粥样硬化作用超过了 oxLDL 免疫接种在 apoE-/- 小鼠中的抗动脉粥样硬化潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验